Sequential changes in autophagy in diabetic cardiac fibrosis

Gao,Huikuan; Yang,Qiong; Dong,Ruiqing; Hou,Fei; Wu,Yongquan

doi:10.3892/mmr.2015.4517

Sequential changes in autophagy in diabetic cardiac fibrosis

Authors:
- Huikuan Gao
- Qiong Yang
- Ruiqing Dong
- Fei Hou
- Yongquan Wu
View Affiliations

Affiliations: Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China, Department of Infection, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, P.R. China
Published online on: November 6, 2015 https://doi.org/10.3892/mmr.2015.4517
Pages: 327-332

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Autophagy is considered to be associated with cardiac fibrosis. However, whether autophagy accelerates or ameliorates fibrosis remains to be elucidated. In the present study, 36 rats were divided into two groups: Control rats and diabetic rats. The diabetic rats were established by feeding the animals a high fat diet combined with streptozotocin. From the two groups, six rats were sacrificed after 1, 6 and 7 months. Cardiac systolic functions were measured. The collagen volume fraction was calculated using Masson's trichome staining and the mRNA expression levels of type‑I and type‑III collagen were measured using reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) to assess the levels of cardiac fibrosis. The protein contents of microtubule‑associated protein 1 light chain 3 (LC3) and sequestosome 1 (P62) were evaluated using western blotting, and the mRNA expression of Beclin 1 was measured using RT‑qPCR, in order to assess autophagy. The results revealed that, in the diabetic rats, cardiac fibrosis developed and cardiac systolic function was reduced. In the hearts of the diabetic rats, the mRNA expression levels of collagen type I and III, and Beclin1 were upregulated; the ratio of the protein level of LC3‑II/LC3‑I was increased and the content of P62 was decreased. All the changes were aggravated as time increased. The changes in autophagy were correlated with those of cardiac fibrosis, suggesting that autophagy may have a synergistic role in diabetic cardiac fibrosis.

View Figures

View References

1	Xu X, Kobayashi S, Chen K, Timm D, Volden P, Huang Y, Gulick J, Yue Z, Robbins J, Epstein PN and Liang Q: Diminished autophagy limits cardiac injury in mouse models of type 1 diabetes. J Biol Chem. 288:18077–18092. 2013. View Article : Google Scholar : PubMed/NCBI
2	Xie Z, Lau K, Eby B, Lozano P, He C, Pennington B, Li H, Rathi S, Dong Y, Tian R, et al: Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes. 60:1770–1778. 2011. View Article : Google Scholar : PubMed/NCBI
3	Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW and Grishman A: New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 30:595–602. 1972. View Article : Google Scholar : PubMed/NCBI
4	Fischer VW, Barner HB and Larose LS: Pathomorphologic aspects of muscular tissue in diabetes mellitus. Hum Pathol. 15:1127–1136. 1984. View Article : Google Scholar : PubMed/NCBI
5	Zhu H, Tannous P, Johnstone JL, Kong Y, Shelton JM, Richardson JA, Le V, Levine B, Rothermel BA and Hill JA: Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest. 117:1782–1793. 2007. View Article : Google Scholar : PubMed/NCBI
6	Onodera J and Ohsumi Y: Autophagy is required for maintenance of amino acid levels and protein synthesis under nitrogen starvation. J Biol Chem. 280:31582–31586. 2005. View Article : Google Scholar : PubMed/NCBI
7	Dorn GW II: Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling. Cardiovasc Res. 81:465–473. 2009. View Article : Google Scholar :
8	Shen S, Kepp O and Kroemer G: The end of autophagic cell death? Autophagy. 8:1–3. 2012. View Article : Google Scholar
9	Hernández-Gea V, Ghiassi-Nejad Z, Rozenfeld R, Gordon R, Fiel MI, Yue Z, Czaja MJ and Friedman SL: Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology. 142:938–946. 2012. View Article : Google Scholar : PubMed/NCBI
10	Mellor KM, Bell JR, Young MJ, Ritchie RH and Delbridge LM: Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. J Mol Cell Cardiol. 50:1035–1043. 2011. View Article : Google Scholar : PubMed/NCBI
11	Nho RS and Hergert P: IPF fibroblasts are desensitized to type I collagen matrix-induced cell death by suppressing low autophagy via aberrant Akt/mTOR kinases. PLoS One. 9:e946162014. View Article : Google Scholar : PubMed/NCBI
12	Srinivasan K, Viswanad B, Asrat L, Kaul CL and Ramarao P: Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening. Pharmacol Res. 52:313–320. 2005. View Article : Google Scholar : PubMed/NCBI
13	Islam MS and Choi H: Nongenetic model of type 2 diabetes: A comparative study. Pharmacology. 79:243–249. 2007. View Article : Google Scholar : PubMed/NCBI
14	Barth S, Glick D and Macleod KF: Autophagy: Assays and artifacts. J Pathol. 221:117–124. 2010. View Article : Google Scholar : PubMed/NCBI
15	Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H and Johansen T: p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol. 171:603–614. 2005. View Article : Google Scholar : PubMed/NCBI
16	Lee HS, Daniels BH, Salas E, Bollen AW, Debnath J and Margeta M: Clinical utility of LC3 and p62 immunohisto-chemistry in diagnosis of drug-induced autophagic vacuolar myopathies: A case-control study. PLoS One. 7:e362212012. View Article : Google Scholar
17	Settembre C, Fraldi A, Jahreiss L, Spampanato C, Venturi C, Medina D, de Pablo R, Tacchetti C, Rubinsztein DC and Ballabio A: A block of autophagy in lysosomal storage disorders. Hum Mol Genet. 17:119–129. 2008. View Article : Google Scholar
18	Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K and Matsuo H: Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation. 101:899–907. 2000. View Article : Google Scholar : PubMed/NCBI
19	Vadlamudi RV, Rodgers RL and McNeill JH: The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance. Can J Physiol Pharmacol. 60:902–911. 1982. View Article : Google Scholar : PubMed/NCBI
20	Kato T, Yamashita T, Sekiguchi A, Sagara K, Takamura M, Takata S, Kaneko S, Aizawa T and Fu LT: What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol. 17:890–894. 2006. View Article : Google Scholar : PubMed/NCBI
21	Boyle AJ, Shih H, Hwang J, Ye J, Lee B, Zhang Y, Kwon D, Jun K, Zheng D, Sievers R, et al: Cardiomyopathy of aging in the mammalian heart is characterized by myocardial hypertrophy, fibrosis and a predisposition towards cardiomyocyte apoptosis and autophagy. Exp Gerontol. 46:549–559. 2011. View Article : Google Scholar : PubMed/NCBI
22	Miyata S, Takemura G, Kawase Y, Li Y, Okada H, Maruyama R, Ushikoshi H, Esaki M, Kanamori H, Li L, et al: Autophagic cardiomyocyte death in cardiomyopathic hamsters and its prevention by granulocyte colony-stimulating factor. Am J Pathol. 168:386–397. 2006. View Article : Google Scholar : PubMed/NCBI
23	Zhang TZ, Fan B, Chen X, Wang WJ, Jiao YY, Su GF and Li GY: Suppressing autophagy protects photoreceptor cells from light-induced injury. Biochem Biophys Res Commun. 450:966–972. 2014. View Article : Google Scholar : PubMed/NCBI
24	Mizushima N and Yoshimori T: How to interpret LC3 immunoblotting. Autophagy. 3:542–545. 2007. View Article : Google Scholar : PubMed/NCBI